1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Optimizing Disease Management to Improve Alopecia Areata Quality of Care - China is sponsored by Pfizer Foundation Inc.. Optimizing Disease Management to Improve Alopecia Areata Quality of Care - China is a grant from Pfizer Foundation Inc.
Get alerted about grants like this
Save a search for “Pfizer Foundation Inc.” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Competitive Grants Program | Pfizer Competitive Grants Program Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.
The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Inflammation & Immunology Support for the Professions British Indian Ocean Territory Congo, The Democratic Republic Falkland Islands (Malvinas) French Southern Territories Heard and Mc Donald Islands Holy See (Vatican City State) Iran (Islamic Republic of) Korea, Democratic People's Rep Lao People's Democratic Republ Macedonia, The Former Yugoslav Micronesia, Federated States o Saint Vincent and the Grenadin Slovakia (Slovak Republic) South Georgia and the South Sa Svalbard and Jan Mayen Islands Tanzania, United Republic of United States Minor Outlying I Wallis and Futuna Islands Optimizing Disease Management to Improve Alopecia Areata Quality of Care Release Date: January 15, 2026 Review Process: Pfizer Internal View RFP (PDF) Quality Improvement Inflammation & Immunology China April 30, 2026 Providing Appropriate Medical Care for IBD Patients Release Date: January 27, 2026 Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD) Review Process: Expert Review Panel View RFP (PDF) Quality Improvement Inflammation & Immunology Japan April 19, 2026 Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) Therapy Release Date: February 4, 2026 Review Process: Pfizer Internal View RFP (PDF) Education Oncology Canada April 22, 2026 Advances in Migraine Management Release Date: February 11, 2026 Review Process: Pfizer Internal View RFP (PDF) Education Internal Medicine USA May 8, 2026 Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local Level Release Date: February 14, 2026 Review Process: Pfizer Internal View RFP (PDF) Quality Improvement Inflammation & Immunology China April 30, 2026 Quality improvement strategies to enhance quality of life in ALK-positive lung cancer patients Release Date: February 26, 2026 Review Process: Pfizer Internal View RFP (PDF) Quality Improvement Oncology Spain April 23, 2026 Efforts to Improve Quality of Migraine Care Release Date: March 4, 2026 Partner: The Japanese Headache Society Review Process: Expert Review Panel View RFP (PDF) Quality Improvement Internal Medicine Japan June 15, 2026 Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC) Release Date: March 4, 2026 Review Process: Pfizer Internal View RFP (PDF) Education Oncology USA April 21, 2026 Enhancing HCP Education in Adult Vaccination against Respiratory Infections Release Date: March 5, 2026 Review Process: Pfizer Internal View RFP (PDF) Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland April 30, 2026 Migraine and Women’s Health Release Date: March 9, 2026 Partner: American Headache Society Review Process: Expert Review Panel View RFP (PDF) Quality Improvement, Research Internal Medicine USA May 5, 2026 Inflammation & Immunology Support for the Professions British Indian Ocean Territory Congo, The Democratic Republic Falkland Islands (Malvinas) French Southern Territories Heard and Mc Donald Islands Holy See (Vatican City State) Iran (Islamic Republic of) Korea, Democratic People's Rep Lao People's Democratic Republ Macedonia, The Former Yugoslav Micronesia, Federated States o Saint Vincent and the Grenadin Slovakia (Slovak Republic) South Georgia and the South Sa Svalbard and Jan Mayen Islands Tanzania, United Republic of United States Minor Outlying I Wallis and Futuna Islands Pneumococcal Disease Prevention Release Date: April 11, 2012 Review Process: View RFP (PDF) Release Date: May 8, 2012 Review Process: View RFP (PDF) Release Date: June 28, 2012 Review Process: View RFP (PDF) Pharmacy Pneumococcal Disease Prevention Release Date: June 28, 2012 Review Process: View RFP (PDF) Release Date: July 2, 2012 Review Process: View RFP (PDF) Non-Small Cell Lung Cancer Release Date: July 10, 2012 Review Process: View RFP (PDF) Cardiovascular Risk in Rheumatoid Arthritis Release Date: July 25, 2012 Review Process: View RFP (PDF) Release Date: July 26, 2012 Review Process: View RFP (PDF) Adult Pneumococcal Disease Prevention Release Date: August 29, 2012 Review Process: View RFP (PDF) Prevention of Stroke in Women Release Date: September 13, 2012 Review Process: View RFP (PDF) Oncology Educational Needs Assessments Release Date: October 22, 2012 Review Process: View RFP (PDF) Release Date: November 1, 2012 Review Process: View RFP (PDF)
Based on current listing details, eligibility includes: Healthcare organizations and professional entities in China. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Not specified Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is April 30, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.